###begin article-title 0
Plasminogen Alleles Influence Susceptibility to Invasive Aspergillosis
###end article-title 0
###begin p 1
Current address: National Jewish Medical and Research Center, Denver, Colorado, United States of America
###end p 1
###begin p 2
Conceived and designed the experiments: AZ SG GP JP DAS. Performed the experiments: AZ SG LP. Analyzed the data: AZ GL CW DS LB GP. Contributed reagents/materials/analysis tools: GL CW DS SG KM JU LB LP GP. Wrote the paper: AZ GL JP GP DAS.
###end p 2
###begin p 3
###xml 607 610 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plg</italic>
###xml 707 716 707 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Gly110Ser</italic>
###xml 868 877 868 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Asp472Asn</italic>
###xml 921 924 921 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 1208 1229 1208 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus fumigatus</italic>
###xml 441 446 <span type="species:ncbi:10090">mouse</span>
###xml 643 649 <span type="species:ncbi:10090">murine</span>
###xml 906 911 <span type="species:ncbi:9606">human</span>
###xml 1208 1229 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Invasive aspergillosis (IA) is a common and life-threatening infection in immunocompromised individuals. A number of environmental and epidemiologic risk factors for developing IA have been identified. However, genetic factors that affect risk for developing IA have not been clearly identified. We report that host genetic differences influence outcome following establishment of pulmonary aspergillosis in an exogenously immune suppressed mouse model. Computational haplotype-based genetic analysis indicated that genetic variation within the biologically plausible positional candidate gene plasminogen (Plg; Gene ID 18855) correlated with murine outcome. There was a single nonsynonymous coding change (Gly110Ser) where the minor allele was found in all of the susceptible strains, but not in the resistant strains. A nonsynonymous single nucleotide polymorphism (Asp472Asn) was also identified in the human homolog (PLG; Gene ID 5340). An association study within a cohort of 236 allogeneic hematopoietic stem cell transplant (HSCT) recipients revealed that alleles at this SNP significantly affected the risk of developing IA after HSCT. Furthermore, we demonstrated that plasminogen directly binds to Aspergillus fumigatus. We propose that genetic variation within the plasminogen pathway influences the pathogenesis of this invasive fungal infection.
###end p 3
###begin title 4
Author Summary
###end title 4
###begin p 5
###xml 763 766 763 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plg</italic>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 537 542 <span type="species:ncbi:10090">Mouse</span>
###xml 614 620 <span type="species:ncbi:10090">murine</span>
###xml 809 815 <span type="species:ncbi:10090">murine</span>
###xml 951 956 <span type="species:ncbi:9606">human</span>
###xml 1137 1143 <span type="species:ncbi:10090">murine</span>
###xml 1154 1159 <span type="species:ncbi:9606">human</span>
Invasive aspergillosis (IA) is the most common invasive mould infection among highly immune compromised hosts. While exogenous immune suppression is the greatest risk factor for infection acquisition, polymorphic variation in key immune effector genes likely contributes to disease susceptibility as well. We hypothesized that susceptibility to invasive aspergillosis was, in part, due to host genetic variation. By screening strains of inbred mice, we demonstrated differential susceptibility to invasive aspergillosis. Using the Roche Mouse single nucleotide polymorphism (SNP) Database, we localized an area on murine chromosome 17 as a putative "quantitative trait locus" governing disease susceptibility. Within this interval, the gene encoding plasminogen (Plg) was found to have a coding change SNP in murine strains that were highly susceptible to disease. Many micro-organisms are recognized to hijack the plasminogen to be more prevalent in human hematopoietic stem cell transplant recipients who developed IA as compared to those who did not. Thus, we demonstrated a genetic basis for increased susceptibility to IA in both a murine model and human cohort, and implicated the fibrinolytic system in the pathogenesis of this disease.
###end p 5
###begin title 6
Introduction
###end title 6
###begin p 7
###xml 24 45 24 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus fumigatus</italic>
###xml 382 385 382 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Herbrecht1">[1]</xref>
###xml 386 389 386 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Marr1">[2]</xref>
###xml 692 695 692 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Marr1">[2]</xref>
###xml 24 45 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 47 49 <span type="species:ncbi:5085">AF</span>
###xml 391 393 <span type="species:ncbi:5085">AF</span>
Invasive infection with Aspergillus fumigatus (AF) is a common and life-threatening infection among severely immunocompromised individuals. Despite aggressive surveillance and prophylaxis, the incidence of invasive aspergillosis (IA) in hematopoietic stem cell transplant (HSCT) recipients remains approximately 10%, and the three month mortality following infection approaches 30% [1],[2]. AF infection leads to a potentially hemorrhagic bronchopneumonia, with angio-invasion and tissue destruction. Several factors have been shown to affect risk for developing IA in allogeneic HSCT recipients. These include immunosuppresion required for HSCT, graft-vs-host-disease, and corticosteroid use[2]. However, despite having similar risk profiles, only a subset of at-risk individuals will develop IA. Since most of the identified risk factors for IA affect the immune system of the recipient, we hypothesize that genetic variation within key innate or adaptive immune response genes could influence susceptibility to or outcome of this invasive fungal infection.
###end p 7
###begin p 8
###xml 261 264 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 366 369 366 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 39 45 <span type="species:ncbi:10090">murine</span>
###xml 360 365 <span type="species:ncbi:9606">human</span>
###xml 390 395 <span type="species:ncbi:9606">human</span>
The susceptibility of different inbred murine strains for developing IA after immunosuppression was analyzed to determine if genetic factors affect susceptibility to aspergillosis. Haplotype-based computational genetic analysis of this survival data identified PLG as a candidate susceptibility gene. A SNP that caused a significant amino acid substitution in human PLG was identified, and human PLG alleles were found to affect risk for developing IA in HSCT recipients.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 7 12 <span type="species:ncbi:10090">Mouse</span>
Inbred Mouse Strains Have Distinct Survival Patterns after Invasive Pulmonary Aspergillosis
###end title 10
###begin p 11
###xml 853 861 853 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000101.s004">Table S1</xref>
###xml 1080 1092 1080 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 1094 1102 1094 1102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000101.s004">Table S1</xref>
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
###xml 124 126 <span type="species:ncbi:5085">AF</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 466 468 <span type="species:ncbi:5085">AF</span>
###xml 774 776 <span type="species:ncbi:5085">AF</span>
###xml 951 953 <span type="species:ncbi:5085">AF</span>
###xml 1035 1037 <span type="species:ncbi:5085">AF</span>
###xml 1080 1092 <span type="species:ncbi:5085">A. fumigatus</span>
Ten inbred mouse strains were transiently immunosuppressed with cyclophosphamide and cortisone acetate prior to exposure to AF conidia. The strain-specific survival patterns were then evaluated over a 14 day period. This immunosuppressive regimen disrupts macrophage and neutrophil-mediated defense against inhaled conidia. In control experiments, no significant mortality was observed in the nine different immunosuppressed strains of mice that were not exposed to AF. However, the immunosuppressive regimen caused significant mortality in the DBA/2 strain. Therefore, subsequent analyses were performed with and without the data from this strain. Since the immunosuppressive regimen was initiated 3 days prior, all strains were rendered neutropenic at time of exposure to AF. The neutropenia extended through day 7 with neutrophil recovery by day 10 (Table S1). Quantitative PCR (qPCR) measurements performed on lung tissue harvested 24 hours after AF exposure indicated that the inbred strains were exposed to equivalent amounts of AF and had an equivalent pulmonary burden of A. fumigatus (Table S1). Thus, the inbred strains received the same immunosuppressive regimen, experienced identical periods of neutropenia, and received the same pulmonary fungal inoculum.
###end p 11
###begin p 12
###xml 118 127 118 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000101-g001">Figure 1A</xref>
###xml 788 797 788 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000101-g001">Figure 1B</xref>
###xml 936 947 936 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus</italic>
###xml 980 992 980 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000101-g001">Figure 1C, D</xref>
###xml 1528 1536 1528 1536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000101.s004">Table S1</xref>
###xml 1926 1929 1926 1929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Poltorak1">[3]</xref>
###xml 2009 2021 2009 2021 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 2092 2099 2092 2099 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tlr4&#8722;/&#8722;</sup>
###xml 2183 2195 2183 2195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 114 116 <span type="species:ncbi:5085">AF</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 390 394 <span type="species:ncbi:10090">mice</span>
###xml 416 418 <span type="species:ncbi:5085">AF</span>
###xml 922 926 <span type="species:ncbi:10090">mice</span>
###xml 1041 1045 <span type="species:ncbi:10090">mice</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
###xml 1185 1187 <span type="species:ncbi:5085">AF</span>
###xml 1614 1616 <span type="species:ncbi:5085">AF</span>
###xml 1707 1709 <span type="species:ncbi:5085">AF</span>
###xml 1835 1839 <span type="species:ncbi:10090">mice</span>
###xml 1846 1848 <span type="species:ncbi:5085">AF</span>
###xml 1876 1880 <span type="species:ncbi:10090">mice</span>
###xml 2009 2021 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 2100 2104 <span type="species:ncbi:10090">mice</span>
###xml 2127 2131 <span type="species:ncbi:10090">mice</span>
###xml 2183 2195 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 2276 2280 <span type="species:ncbi:10090">mice</span>
Despite this, the inbred strains exhibited significant and reproducible differences in survival after exposure to AF (Figure 1A). The "susceptible" inbred strains (A/J and C3H/HeJ) exhibited 100% mortality by day 6. The DBA/2J strain also experienced 100% mortality by day 6; however the survival curves for immune suppressed unexposed DBA/2J mice were not significantly different from the mice that were exposed to AF (data not shown). The "intermediate" strains (MRL/MPJ and NZW/LacJ) also experienced 100% mortality; however the majority of deaths in these strains occurred between days 5 and 10. Five strains exhibited a "resistant" pattern of survival: (AKR/J, C57/Bl6J, 129/SvJ, Balb/CJ, and Balb/CByJ); they had between 30-60% survival at the end of the 14 day observation period (Figure 1B). The survival patterns were reproducible on repeated experimental trials. Histological evaluation of the lungs of moribund mice revealed Aspergillus hyphae and foci of pneumonitis (Figure 1C, D). Overt histologic differences between moribund mice from each strain were not noted, however histologic sections from surviving mice noted resolving pneumonia (data not shown). The amount of AF in the lung 48 hours after infection was also measured by qPCR. At 48 hours, the fungal burden in the sensitive strains (median conidial equivalents 4.7 log cells/gram lung tissue; range 3.8-5.0) was significantly greater (p = 0.02) than in the resistant strains (median conidial equivalents 3.7 log cells/gram lung tissue; range 2.7-5.3) (Table S1). Despite having the same level of immunosuppression and initial exposure to AF, the inbred strains exhibited significant differences in fungal burden and survival after AF exposure. These findings suggest that genetic factors affect the control of fungal burden, and survival in immune suppressed mice after AF exposure. Notably, C3H/HeJ mice are known to have defective TLR-4 signalling [3]. To evaluate the role of TLR-4 hypofunction in outcome following inhalation of A. fumigatus, both non-immune compromised and exogenously immune compromised C57Bl6tlr4-/- mice were evaluated. These mice exhibited a "resistant" phenotype upon exposure to A. fumigatus in this model (data not shown). Thus, the survival pattern exhibited by C3H/HeJ mice in our model was not felt to be solely due to hypofunction of TLR4.
###end p 12
###begin title 13
###xml 56 68 56 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 56 68 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Survival following immune suppression and inhalation of A. fumigatus differs among inbred strains of mice.
###end title 13
###begin p 14
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 650 662 650 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 41 47 <span type="species:ncbi:10090">murine</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 588 594 <span type="species:ncbi:10090">murine</span>
###xml 650 662 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 702 706 <span type="species:ncbi:10090">mice</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 782 786 <span type="species:ncbi:10090">mice</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
###xml 906 911 <span type="species:ncbi:10090">mouse</span>
###xml 975 977 <span type="species:ncbi:5085">AF</span>
###xml 1074 1076 <span type="species:ncbi:5085">AF</span>
(A) 14-day survival phenotype for inbred murine strains following immunosuppression and inhalation of 3.0x108 AF293 conidia. Susceptible strains had death of all mice by day 6 following infection. Intermediate strains had death predominately during neutrophil recovery (days 8-11) and resistant strains had surviving mice at day 14. N = 10 mice per strain. Repetitions of the inhalation in C57Bl/6, Balb/C, A/J and C3H/HeJ yielded similar results, indicating reproducibility of phenotype and consistency of inhalational protocol. (B) Kaplan-Meier curve representing divergent outcomes of murine strains following immune suppression and inhalation of A. fumigatus. Death occurred earlier in susceptible mice as compared to intermediate and resistant mice, as well as in intermediate mice as compared to resistant mice (p<0.001, log rank). (C) Haematoxylin and eosin stain of A/J lung, taken from a moribund mouse 4 days following immune suppression and inhalation of 3.0x10e8 AF conidia, magnification 40x. 1d. Gomori-methanamine silver stain of A/J lung, showing a focus of AF hyphae, magnification 40x.
###end p 14
###begin title 15
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
Computational Genetic Analysis Identifies Plasminogen (PLG) as a Candidate Susceptibility Gene for Invasive Aspergillosis
###end title 15
###begin p 16
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Grupe1">[4]</xref>
###xml 169 172 169 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Guo1">[5]</xref>
###xml 173 176 173 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Liao1">[6]</xref>
###xml 527 535 527 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000101-g002">Figure 2</xref>
###xml 537 547 537 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000101.s001">Figure S1A</xref>
###xml 646 652 646 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ugcgl1</italic>
###xml 671 674 671 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 683 689 683 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ugcgl1</italic>
###xml 776 779 776 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Bianchini1">[7]</xref>
###xml 876 879 876 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 941 944 941 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Berge1">[8]</xref>
###xml 945 949 945 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Sun1">[18]</xref>
###xml 1167 1170 1167 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 1257 1267 1257 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000101.s001">Figure S1B</xref>
###xml 1269 1278 1269 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000101.s002">Figure S2</xref>
###xml 53 55 <span type="species:ncbi:5085">AF</span>
###xml 271 277 <span type="species:ncbi:10090">murine</span>
###xml 383 385 <span type="species:ncbi:5085">AF</span>
To identify genetic factors affecting survival after AF exposure, the inbred strain survival data were analyzed using haplotype-based computational genetic analysis [4],[5],[6]. This analysis identifies genomic regions where the pattern of genetic variation among inbred murine strains correlates with a pattern of phenotypic responses. The area under the survival curve (AUC) after AF exposure was analyzed; and 2 haplotype blocks were identified where the pattern of genetic variation had a strong correlation with survival (Figure 2, Figure S1A). The top two predicted loci contained the genes UDP-glucose ceramide glucosyltransferase-like 1 (Ugcgl1) and Plasminogen (PLG). While Ugcgl1, a glycoprotein glucosyltransferase, may have some role in CD4/CD8 thymocyte function [7], recent reports linking the fibrinolytic system with host response to infectious pathogens made PLG an attractive candidate for influencing susceptibility to IA [8]-[18]. Because the immunosuppressive regimen induced mortality in the DBA/2 strain, the computational analysis was also repeated using survival data that did not include this strain. When this reduced dataset was analyzed, PLG was among the genomic regions whose pattern of genetic variation correlated survival (Figure S1B, Figure S2).
###end p 16
###begin title 17
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
Computational genetic analysis identifies plasminogen (PLG) as a candidate susceptibility gene for invasive aspergillosis.
###end title 17
###begin p 18
###xml 154 156 <span type="species:ncbi:5085">AF</span>
###xml 279 285 <span type="species:ncbi:10090">murine</span>
###xml 413 419 <span type="species:ncbi:10090">murine</span>
Haplotype-based computational genetic analysis was used to analyze the area under the survival curve to identify genetic factors affecting survival after AF exposure among the inbred strains. Colored blocks represent haplotype structure, with red blocks representing "resistant" murine strains (C57, 129, Balb/C, Balb/CBy and AKR) and the "intermediate" strain NZW/LacJ and blue blocks representing "susceptible" murine strains (A/J, DBA/2J and C3H/HeJ) and the "intermediate" strain MR/MpJ. The green block represents missing haplotype data.
###end p 18
###begin p 19
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 94 106 94 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mus musculus</italic>
###xml 171 174 171 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Suenson1">[19]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-HoTinNoe1">[20]</xref>
###xml 94 106 <span type="species:ncbi:10090">Mus musculus</span>
###xml 713 717 <span type="species:ncbi:10090">mice</span>
###xml 722 728 <span type="species:ncbi:9606">humans</span>
PLG was sequenced across 20 inbred strains, and 423 SNPs were identified. Among the 10 inbred Mus musculus strains characterized here, the pattern of genetic variation in PLG was organized into 2 haplotype blocks. The 129, AKR, Balb/c, Balb/cBy, C57, and NZW strains had one haplotype, while the AJ, MRL, DBA and C3H strains had the other haplotype. There was a single non-synonymous SNP that altered an amino acid (G110S). This non-conservative amino acid substitution is within the first kringle domain, which regulates the initial binding of plasminogen to fibrin as well as plasmin-induced cell-detachment [19],[20]. The glycine at this position is conserved across all five kringle domains of plasminogen in mice and humans, suggesting that this amino acid change may have significant functional importance. Notably, the susceptible strains had the minor allele (Ser) at this position, which was not present in the resistant strains.
###end p 19
###begin title 20
###xml 6 9 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human PLG Alleles also Affect Susceptibility to Invasive Aspergillosis
###end title 20
###begin p 21
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 152 155 152 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 518 521 518 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Herbrecht1">[1]</xref>
###xml 522 525 522 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Marr1">[2]</xref>
###xml 703 710 703 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000101-t001">Table 1</xref>
###xml 31 37 <span type="species:ncbi:10090">murine</span>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 311 319 <span type="species:ncbi:9606">patients</span>
Since an allelic difference in murine PLG was associated with susceptibility in a mouse model, it was possible that polymorphisms in human plasminogen (PLG) could also affect susceptibility to IA. If true, the best chance for detecting a genetic effect would be through analysis of a cohort of immunosuppressed patients that is at increased risk of developing invasive aspergillosis. The incidence of invasive aspergillosis in allogeneic HSCT recipients, which undergo intensive immunosuppression is approximately 10% [1],[2]. Therefore, HSCT recipients, followed for at least one year after transplant, provide an ideal population for identifying the genetic factors associated with IA susceptibility (Table 1).
###end p 21
###begin title 22
Demographics of HSCT Recipients.
###end title 22
###begin p 23
###xml 86 93 <span type="species:ncbi:9606">persons</span>
subjects were censored if follow-up ended prior to day 100% calculated based on total persons in each time period IA = invasive aspergillosis CLL = chronic lymphocytic leukemia; CML = chronic myelocytic leukemia; ALL = acute lymphoblastic leukemia AML = acute myeloblastic leukemia; NHL = non-Hodgkin's lymphoma; PBSC = peripheral blood stem cells ANL = acute nonlymphoblastic leukemia; AA = aplastic anemia; MM = multiple myeloma; MDS = myelodysplastic syndrome; AGVHD = acute graft-versus-host disease; CGVHD = chronic graft-versus-host disease.
###end p 23
###begin p 24
Of 87 total Caucasian HSCT donor-recipient pairs with IA sequenced, two were excluded due to missing data and two were excluded due to IA occurring during a second stem cell transplant. Only 2 of a total of 149 HSCT donor-recipient pairs that did not develop IA were excluded from this analysis. One pair was excluded due to having a second stem cell transplant and one was excluded due to missing data.
###end p 24
###begin p 25
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 658 660 658 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 105 110 <span type="species:ncbi:9606">human</span>
###xml 799 805 <span type="species:ncbi:10090">murine</span>
To perform the human genetic study, we first had to characterize the pattern of genetic variation in the human plasminogen gene. To do this, all exons and the promoter region of PLG were sequenced in 20 HSCT donor-recipient pairs (40 DNA samples from 20 stem cell donors and 20 stem cell recipients). Although 4 SNPs causing an amino acid change were identified, only one of these SNPs had a minor allele frequency above 1%. Therefore, our analysis focused upon SNP rs4252125 (Asp472Asn), which had a minor allele frequency (Asn472) of 25%. This non-conservative (neutral to acidic amino acid) substitution occurs in a loop region that connects the 4th and 5th kringle domains of plasminogen. This loop region can form highly variable structures based on the surrounding environment. Similar to the murine polymorphism, this amino acid change could have a significant functional impact through altering the alignment of kringle domains or ligand binding.
###end p 25
###begin p 26
###xml 903 906 903 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Marr1">[2]</xref>
###xml 1310 1318 1310 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000101-g003">Figure 3</xref>
###xml 1320 1327 1320 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000101-t002">Table 2</xref>
###xml 1518 1521 1518 1521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 2241 2252 2241 2252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus</italic>
###xml 2331 2342 2331 2342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus</italic>
###xml 160 167 <span type="species:ncbi:9606">persons</span>
The genotype at Asp472Asn for the remainder of the HSCT cohort was then determined. Genotype was interpreted in a blinded manner, such that the two independent persons analyzing genotype data were unaware of each subject's status as a case or control. Analysis of these data indicated that HSCT recipients that were homozygous or heterozygous for Asn472 (AA or AG genotype) were at a significantly increased risk of developing IA after transplant. The Asn472 allele was present with greater frequency in HSCT recipients who developed IA (47/83; 56%) as compared to those who did not (62/147; 42%). Importantly, the genotype-specific risk for developing IA was not constant over time after transplant. Risk for development of IA following HSCT is bimodal, with peak risk periods occurring during the pre-engraftment phase (<day 40) and a second peak during the post-engraftment phase, during days 40-100 [2]. To allow for possible violations of the proportional hazards assumption, the genotypic hazard ratios were evaluated during 3 distinct time periods post HSCT: days 0-40, days 40-100 and days 100-365. There was a constant and substantial elevation in the genotype-specific hazard ratio for IA among recipients who carried at least one "Asn" allele (AA or AG genotype) between 40-365 days following HSCT (Figure 3, Table 2). Perhaps due to a low number of cases of IA occurring during days 0-40 or to the confounding effects of known strong risk factors pre-engraftment (e.g. neutropenia), an association between PLG genotype and IA was not observed during the first 40 days after transplant. For follow-up after day 40, the recipient plasminogen genotype remained a significant risk factor for IA susceptibility (p<0.0005) when a multivariate analysis was used to simultaneously account for effects of other factors that were significant in univariate analysis (HLA matching status, source of stem cells, and underlying malignancy). In addition, there was an apparent gene-dosage effect: homozygous AsnAsn individuals were at a 5.6-fold increased risk of developing IA, while heterozygous individuals had a 3.0 fold increased risk, relative to AspAsp individuals. A majority (96%) of subjects received fluconazole prophylaxis (no anti-Aspergillus activity), with the remainder receiving itraconazole, which does possess anti-Aspergillus activity (4%). Type of prophylaxis did not differ significantly between cases and controls. Inclusion of prophylaxis in the risk model revealed that the type of prophylaxis was not predictive of acquiring invasive aspergillosis, nor did the results related to genotype change with adjustment for type of prophylaxis. Notably, donor polymorphism status was not associated with development of aspergillosis. This served as an important negative control; plasminogen is synthesized hepatically, and thus, the donor plasminogen genotype should not associate with disease acquisition.
###end p 26
###begin title 27
Kaplan-Meier curve demonstrating elevated risk of developing IA in HSCT recipients with AA or AG genotype, using GG as the reference genotype.
###end title 27
###begin p 28
The data represent 59 HSCT recipients who developed IA between days 40-365 following transplantation and 135 HSCT recipients who survived >40 days following HSCT and did not develop IA (HR genotype AA 5.56, 95% CI 1.88, 16.48; HR genotype AG 3.00 95% CI 1.46, 6.14; p<0.0005). The genotypic results are reported for follow-up beyond 40 days, using a left-censored analysis.
###end p 28
###begin title 29
Recipient Plg genotype is a risk factor for development of invasive aspergillosis after day 40 following HSCT.
###end title 29
###begin p 30
HSCT recipients with "AA" (Asn/Asn) or "AG" (Asp/Asn) genotype are at increased risk of developing invasive aspergillosis following transplant as compared to HSCT recipients with "GG" (Asp/Asp) genotype. The data were adjusted for cell type, HLA match, and malignancy category. The "GG" (Asp/Asp) genotype is the referent category.
###end p 30
###begin p 31
###xml 429 436 429 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000101-t002">Table 2</xref>
###xml 270 278 <span type="species:ncbi:9606">patients</span>
###xml 578 583 <span type="species:ncbi:9606">human</span>
###xml 622 628 <span type="species:ncbi:10090">murine</span>
###xml 685 693 <span type="species:ncbi:9606">patients</span>
During the 40-365 days following transplant, 59 HSCT recipients developed IA; and 135 HSCT recipients who survived for more than 40 days following HSCT did not develop IA. The analysis of survival following diagnosis of IA showed somewhat reduced risk of death among IA patients with the same genotypes, with the hazard ratio for AsnAsn = 0.32 95% CI = (0.11, 0.89) and the hazard ratio for AspAsn = 0.79, 95% CI = (0.43, 1.44) (Table 2). Thus, an allelic difference causing an amino acid change in plasminogen is associated with increased risk for developing IA in a high-risk human cohort, as well as in an experimental murine model, and may also be associated with survival in HSCT patients who develop IA (p = 0.07).
###end p 31
###begin title 32
###xml 27 29 <span type="species:ncbi:5085">AF</span>
Plasminogen Interacts with AF
###end title 32
###begin p 33
###xml 157 159 157 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 165 167 165 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 259 263 259 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-HoTinNoe1">[20]</xref>
###xml 574 576 574 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">st</sup>
###xml 593 602 593 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pgen.1000101.s003">Figure S3</xref>
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Collen1">[12]</xref>
###xml 747 751 747 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Gong1">[21]</xref>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Lahteenmaki1">[22]</xref>
###xml 814 822 814 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000101-g004">Figure 4</xref>
###xml 1207 1211 1207 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Fox1">[14]</xref>
###xml 1212 1216 1212 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Jong1">[23]</xref>
###xml 1408 1420 1408 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000101-g005">Figure 5C, D</xref>
###xml 1675 1684 1675 1684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000101-g005">Figure 5A</xref>
###xml 1880 1889 1880 1889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000101-g005">Figure 5A</xref>
###xml 1947 1956 1947 1956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000101-g005">Figure 5B</xref>
###xml 2098 2107 2098 2107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pgen-1000101-g005">Figure 5B</xref>
###xml 2915 2919 2915 2919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Coleman1">[11]</xref>
###xml 318 324 <span type="species:ncbi:10090">murine</span>
###xml 795 800 <span type="species:ncbi:9606">human</span>
###xml 1121 1123 <span type="species:ncbi:5085">AF</span>
###xml 1335 1337 <span type="species:ncbi:5085">AF</span>
###xml 1400 1406 <span type="species:ncbi:10090">murine</span>
###xml 1444 1446 <span type="species:ncbi:5085">AF</span>
###xml 1502 1508 <span type="species:ncbi:10090">murine</span>
###xml 1513 1518 <span type="species:ncbi:9606">human</span>
###xml 1616 1618 <span type="species:ncbi:5085">AF</span>
###xml 1892 1897 <span type="species:ncbi:9606">Human</span>
###xml 1999 2005 <span type="species:ncbi:10090">murine</span>
###xml 2079 2084 <span type="species:ncbi:9606">human</span>
###xml 2123 2129 <span type="species:ncbi:9913">bovine</span>
###xml 2159 2161 <span type="species:ncbi:5085">AF</span>
###xml 2237 2239 <span type="species:ncbi:5085">AF</span>
###xml 2375 2377 <span type="species:ncbi:5085">AF</span>
###xml 2449 2451 <span type="species:ncbi:5085">AF</span>
We next sought to identify possible mechanisms by which plasminogen may influence susceptibility to invasive aspergillosis. The lysine binding sites in the 1st and 4th kringle domains of plasminogen mediate plasminogen binding to fibrinogen and other targets [20]. Analysis of the theoretical crystal structure of the murine kringle domain 1 revealed that substitution of serine for glycine at this position increased the negativity of the electrostatic potential around the principal lysine binding site. Such a change could increase the affinity of lysine binding to the 1st kringle domain (Figure S3). Since plasminogen is more easily activated after binding, this amino acid substitution could increase the rate of plasminogen activation [12],[21],[22]. Analysis of the crystal structure of human plasminogen (Figure 4) kringle 4 (K4) and kringle 5 (K5) revealed that a substitution of asparagine for aspartic acid at position 472, located in the loop connecting K4 and K5, could potentially influence K4-K5 interactions or binding at the K4 lysine binding site (LBS). Although an interaction between plasminogen and AF has not been previously described, plasminogen does bind to other fungal pathogens [14],[23]. Therefore, immunofluorescence microscopy and flow cytometric analysis were used to determine if plasminogen bound to AF. Immunofluorescence microscopy demonstrated that FITC-labeled murine (Figure 5C, D) bound to both swollen AF conidia and hyphae in a dose dependent manner. Neither murine nor human plasminogen bound resting conidia (data not shown). The dose-dependent binding of plasminogen to AF was confirmed and further quantified by flow cytometry (Figure 5A). Furthermore, specificity of the interaction was tested using pre-incubation of swollen conidia with unlabeled plasminogen. This pre-incubation inhibited the binding of the labeled plasminogen (Figure 5A). Human plasminogen bound to swollen conidia and hyphae (Figure 5B), and demonstrated similar specificity as murine plasminogen, with inhibition of binding by pre-incubation with unlabeled human plasminogen (Figure 5B). FITC-labeled bovine serum albumin (BSA) bound to AF conidia to a lesser degree than labeled plasminogen, and pre-incubation of AF conidia with 0.1% BSA did not inhibit binding of labeled plasminogen (data not shown), highlighting the specificity of the plasminogen-AF interaction. These observations indicate that both infectious forms of AF can directly bind plasminogen, which supports the possibility that the plasminogen system plays an important role in the pathogenesis of IA. This also suggests a plausible mechanism by which the polymorphisms could alter susceptibility to invasive aspergillosis. A polymorphism that enhances plasminogen binding to the pathogen will increase plasminogen activation on the pathogen surface, which could facilitate pathogen entry and pathogen-induced tissue damage [11].
###end p 33
###begin title 34
###xml 77 82 <span type="species:ncbi:9606">human</span>
Ribbon diagrams of the combined kringle 4 (K4) and kringle 5 (K5) domains of human plasminogen.
###end title 34
###begin p 35
(A) Ribbon diagram showing Asp472 and the relationship to a major lysine binding site (LBS) on kringle 4. (B) Asp472 in the native K4K5 structure mutated to Asn.
###end p 35
###begin title 36
###xml 42 54 42 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
###xml 11 16 <span type="species:ncbi:9606">human</span>
###xml 42 54 <span type="species:ncbi:5085">A. fumigatus</span>
Murine and human plasminogen bind swollen A. fumigatus conidia and hyphae.
###end title 36
###begin p 37
###xml 10 22 10 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 109 112 109 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 278 281 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 668 680 652 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 694 695 678 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 722 725 706 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 860 872 834 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 933 936 907 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 10 22 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 85 91 <span type="species:ncbi:10090">murine</span>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 668 680 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 715 721 <span type="species:ncbi:10090">murine</span>
###xml 860 872 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 926 932 <span type="species:ncbi:10090">murine</span>
(A and B) A. fumigatus conidia (1x106) were incubated with several concentrations of murine (A) or human (B) PLG-AF488 (FITC) for 30 minutes at 37degreesC. Binding was assessed by flow cytometry. There was a strong correlation between the geometric mean of the FITC channel and PLG-AF488 concentration. Results are reported as the geometric mean+/-the standard error of the mean of at least three experiments. Specificity of binding is demonstrated as pre-incubation with 4 ug/mL unlabeled plasminogen for 30 minutes at 37degreesC inhibits binding of AF488-labeled plasminogen. Results are reported as the geometric mean+/-the standard error of three replicates. (C.) A. fumigatus conidia (1x106) were stained with murine PLG-AF488 (0.2 microg/ml) and Calcoflour White for 30 minutes at 37degreesC. Plasminogen binding is evident on the conidial surface. (D.) A. fumigatus hyphae were incubated with several concentrations of murine PLG-AF488 for 30 minutes at 37degreesC and calcofluor white and visualized with fluorescence microscopy. Preincubation (30 minutes at 37degreesC) of hyphae with unlabelled plasminogen inhibits binding of AF488-labeled plasminogen.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 24 28 <span type="species:ncbi:10090">mice</span>
###xml 33 39 <span type="species:ncbi:9606">humans</span>
###xml 262 264 <span type="species:ncbi:5085">AF</span>
###xml 420 426 <span type="species:ncbi:10090">murine</span>
###xml 525 530 <span type="species:ncbi:9606">human</span>
###xml 942 950 <span type="species:ncbi:9606">patients</span>
###xml 1178 1186 <span type="species:ncbi:9606">patients</span>
Our genetic analyses in mice and humans indicate that plasminogen alleles affect risk for developing invasive aspergillosis in the immunocompromised state. This association is also supported by functional in vitro studies demonstrating that plasminogen binds to AF. To our knowledge, this is the first attempt to identify genetic polymorphisms affecting risk of IA using a multi-species genetic mapping approach, with a murine model system targeting a polymorphic susceptibility gene which is then assessed in a well-defined human cohort. This approach, unlike a pure candidate gene approach, allowed evaluation of a gene that would be unlikely to be selected a priori for evaluation. While clinical applications of this finding will require further prospective evaluation, the finding can serve as a proof-of-principle paradigm for this staged approach to identifying host genetic polymorphisms that can affect outcome in immune compromised patients. Identification of a genetic polymorphism that influences infectious outcome after HSCT has important implications for pre and post transplant care, and may also have implications for the management of other immune-compromised patients. For example, genetic testing could identify high risk individuals who may benefit from use of broad-spectrum antifungal agents or enhanced monitoring for infection. While plasminogen polymorphisms are associated with development of invasive aspergillosis in HSCT recipients, it remains to be determined whether this allelic variant affects the risk of developing invasive aspergillosis after chronic corticosteroid use, semi-invasive aspergillosis or allergic bronchopulmonary aspergillosis.
###end p 39
###begin p 40
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Sun1">[18]</xref>
###xml 1035 1039 1035 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Boyle1">[10]</xref>
###xml 1181 1184 1181 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Bower1">[9]</xref>
###xml 1185 1189 1185 1189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-SandersonSmith1">[16]</xref>
###xml 1190 1194 1190 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Ge1">[24]</xref>
###xml 1211 1215 1211 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Crowe1">[13]</xref>
###xml 1216 1220 1216 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Fox1">[14]</xref>
###xml 1221 1225 1221 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Jong1">[23]</xref>
###xml 1308 1312 1308 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Bouchara1">[25]</xref>
###xml 1313 1317 1313 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Tronchin1">[26]</xref>
###xml 1700 1704 1700 1704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Mitchell1">[27]</xref>
###xml 1705 1709 1705 1709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Weide1">[30]</xref>
###xml 1802 1806 1802 1806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Levi1">[15]</xref>
###xml 1807 1811 1807 1811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Lahteenmaki1">[22]</xref>
###xml 599 601 <span type="species:ncbi:5085">AF</span>
###xml 1233 1235 <span type="species:ncbi:5085">AF</span>
###xml 2002 2004 <span type="species:ncbi:5085">AF</span>
Additionally, these findings implicate the fibrinolytic pathway as an important mediator of fungal infection. The fibrinolytic pathway is increasingly recognized in infectious disease pathogenesis, and this is the first report to link plasminogen with a filamentous fungus. Several mechanisms may explain how genetic changes affecting the function of plasminogen and the fibrinolytic system could influence host susceptibility to IA. IA is characterized by hemorrhage and tissue destruction, which are mediated by the plasminogen system. As previously demonstrated for streptococcal infection [18], AF-induced plasminogen activation could trigger plasminogen-mediated destruction of extracellular matrix components, which in turn enhances tissue invasiveness of the pathogen. Genetic differences that alter the coagulative function of plasminogen may also influence disease pathogenesis by promoting pulmonary hemorrhage and infarction. Immobilization of plasminogen on the pathogen surface allows for easier activation of this zymogen[10]. This brings the activated enzyme into close contact with key substrates in the basement membrane, which increases the virulence of bacteria [9],[16],[24] and other fungi [13],[14],[23]. Since AF adheres to components in the extracellular matrix and basement membrane [25],[26], its ability to bind plasminogen could be an important virulence mechanism. Since plasminogen plays an important role is inflammation and host defense, this provides another potential mechanism for the plasminogen system to affect the pathogenesis of IA. Plasminogen is a direct chemotaxin and is an activator of monocytes, and has recently been shown to prevent monocyte apoptosis [27]-[30]. A bidirectional relationship between coagulation and inflammation has long been recognized [15],[22]. Since monocytes/macrophages are critical for host defense, genetic variation in plasminogen could cause subtle differences in immune function that may also affect outcome after exposure to AF in severely immune compromised hosts.
###end p 40
###begin p 41
Although death rates following infection tended to be reduced among carriers of the same genotypes that conferred increased risk, this finding may well be due to chance, as it was not statistically significant (p = 0.07). However, puzzling the finding, if this proves statistically significant in another population, it is of profound importance since it dissociates risk from acquisition of disease from survival. Clinical outcome following development of IA hinges not only on immune recovery to limit fungal related pulmonary hemorrhage and tissue infarction, but also on control of an over-exuberant inflammatory response as the immune system recovers. Thus, some of those who develop IA despite carrying the protective AspAsp genotype may respond differently to infection than those carrying the AsnAsn genotype. An additional possibility is that carriers of the AsnAsn genotype who develop IA tend to have a more evident phenotype and consequently are either more readily diagnosed or are diagnosed at an earlier stage of disease. Thus carriers would have elevated risk of diagnosis but would present with a more clinically manageable form of IA.
###end p 41
###begin p 42
###xml 105 109 105 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Kesh1">[31]</xref>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Seo1">[32]</xref>
###xml 354 358 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Kesh1">[31]</xref>
###xml 405 409 405 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Seo1">[32]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Bellocchio1">[33]</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Overland1">[38]</xref>
###xml 595 602 595 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tlr4&#8722;/&#8722;</sup>
###xml 908 912 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Hector1">[39]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 227 232 <span type="species:ncbi:9606">human</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 763 767 <span type="species:ncbi:10090">mice</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
Human association studies in smaller independent HSCT cohorts have implicated Toll-like receptor 1 and 6 [31] and IL-10 receptor [32] polymorphisms as risk factors for development of invasive aspergillosis, While the published human association studies target viable candidate genes based on the prior literature, they are hampered by small size (n = 22 [31] and n = 9, including 4 cases of "possible" IA [32]). Additionally, conflicting data exist on the role of other common innate immune deficiencies (i.e. TLR2 and TLR4 hypofunction) in the pathogenesis of IA [33]-[38]. Our work with C57Bl6tlr4-/- mice did not find TLR4 to be essential for host defense against IA (data not shown), thus unlikely to be the sole reason for enhanced susceptibility of C3H/HeJ mice who are known to have TLR4 hypofunction. Similarly, where deficiency in complement 5a (C5a) may influence outcome in invasive aspergillosis [39], the varying phenotypes between A/J and AKR/J (both C5a deficient) mice indicate that C5a deficiency alone is unlikely to account for the poor survival of A/J mice.
###end p 42
###begin p 43
###xml 156 162 <span type="species:ncbi:10090">murine</span>
###xml 167 172 <span type="species:ncbi:9606">human</span>
###xml 398 406 <span type="species:ncbi:9606">patients</span>
A polymorphism in the gene for plasminogen may confer increased risk of invasive aspergillosis following bone marrow transplantation. The identification of murine and human genetic polymorphisms associated with susceptibility to invasive fungal infection in immunosuppressed hosts enables subsequent epidemiologic and clinical studies that can produce improved methods for management of transplant patients.
###end p 43
###begin title 44
Methods
###end title 44
###begin title 45
Immunosuppression
###end title 45
###begin p 46
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">Mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
Inbred 6-8 week-old female mice (Jackson Laboratories; Bar Harbour, ME) were housed and fed under aseptic conditions and their sterile water was supplemented with tetracycline (1 mg/ml) changed once daily. Ten inbred strains were utilized (BalbC/ByJ, Balb/CJ, AKR/J, 129/SvJ, C57Bl/6J, MRL/MPJ, NZW/LACJ, A/J, DBA/2J and C3H/HeJ). Mice weighed between 18-24 grams, with the exception of MRL/MPJ mice (28-32 grams).
###end p 46
###begin p 47
###xml 4 8 <span type="species:ncbi:10090">mice</span>
The mice were immunosuppressed with an intraperitoneal injection of cyclophosphamide (Sigma Biochemicals, St. Louis, MO) (150 mg/kg) on day -3, and a subcutaneous injection of cortisone acetate (Sigma Biochemicals, St. Louis, MO) (250 mg/kg) on day -1 of infection. The immunosuppressive regimen also included additional doses of cyclophosphamide (150 mg/kg) on days +1, and +4 of infection. All animal work was approved by the Institutional Animal Use and Care Committee at Duke University Medical Center and followed the standard guidelines for ethical treatment of animals.
###end p 47
###begin title 48
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus fumigatus</italic>
###xml 0 21 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Aspergillus fumigatus Strain
###end title 48
###begin p 49
###xml 428 429 428 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 0 2 <span type="species:ncbi:5085">AF</span>
###xml 114 116 <span type="species:ncbi:5085">AF</span>
AF strain 293 was used in all experiments (provided by Dr. William J. Steinbach, Duke University Medical Center). AF conidia were grown on Sabouraud dextrose agar (Difco; Becton Dickinson; Sparks, MD) for 7 days and harvested in 0.01% Tween 80 in sterile water on the day prior to inoculation. Conidia were washed and resuspended in sterile water and counted on a Neubauer hematocytometer to create a conidial suspension of 3x108 conidia/ml.
###end p 49
###begin title 50
Inoculation with Conidia
###end title 50
###begin p 51
###xml 70 71 70 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Hinners1">[40]</xref>
###xml 258 262 258 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Steinbach1">[41]</xref>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
10 mice per strain were immunosuppressed. A total of 40 ml of the 3x108 conidia/ml suspension was aerosolized in four separate nebulizers (Aerotech II, CIS-US, Inc., Beford, MA) in a Hinners-style exposure chamber [40] for 25 minutes as previously described [41]. Select strains (C3H/HeJ, A/J, C57Bl/6J and Balb/CJ) were evaluated a total of 3 times each to ensure reproducibility of findings, thus the total number of mice evaluated was 160.
###end p 51
###begin title 52
Computational Haplotype Mapping
###end title 52
###begin p 53
###xml 108 111 108 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Grupe1">[4]</xref>
###xml 112 115 112 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Liao1">[6]</xref>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Guo2">[42]</xref>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Wang1">[43]</xref>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Wang2">[44]</xref>
###xml 793 796 793 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Liao1">[6]</xref>
###xml 797 801 797 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Wang1">[43]</xref>
###xml 802 806 802 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Wang2">[44]</xref>
###xml 231 236 <span type="species:ncbi:10090">mouse</span>
###xml 911 915 <span type="species:ncbi:10090">mice</span>
Haplotype-based computational genetic analysis of the phenotypic data was performed as previously described [4],[6],[42],[43],[44]. In brief, allelic data from multiple inbred strains were analyzed and a haplotype block map of the mouse genome was constructed. SNPs were organized into haplotype blocks. Only a limited number of haplotypes-typically 2, 3 or 4-are present within a haplotype block. This analysis identifies haplotype blocks in which the haplotypic strain grouping within a block correlates with the distribution of phenotypic data among the inbred strains analyzed. To do this, a p-value that assesses the likelihood that genetic variation within each block could underlie the observed distribution of phenotypes among the inbred strains is calculated as described using ANOVA [6],[43],[44]. The phenotypic data was evaluated using the average value for each strain, obtained by assessing 10-30 mice per strain. The haplotype blocks are then ranked based upon the calculated p-value. The genomic regions within haplotype blocks that strongly correlated with the phenotypic data are then analyzed. When the computational analysis was performed, there were 1745 haplotype blocks that were generated from analysis of 160,000 SNPs with alleles characterized across 18 inbred strains covering 2,171 genes. For this analysis, the candidate haplotype blocks that were empirically selected had p-value<0.005. This was the best p-value achieved by blocks in which the 10 strains are grouped into two haplotypes such that the phenotypes of strains in one haplotype are separated from those of strains in another haplotype.
###end p 53
###begin title 54
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse Genomic Sequencing
###end title 54
###begin p 55
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 88 91 88 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Grupe1">[4]</xref>
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Genomic sequencing of PLG in inbred mouse strains was performed as previously described [4]; and covered the 2 kb 5' upstream, 1 kb 3' downstream, intron-exon junctions and all exonic regions.
###end p 55
###begin title 56
###xml 13 24 13 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Aspergillus</italic>
Quantitative Aspergillus PCR
###end title 56
###begin p 57
###xml 89 90 89 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 142 147 142 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Bowman1">[45]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Walsh1">[46]</xref>
###xml 640 644 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Bowman1">[45]</xref>
###xml 0 2 <span type="species:ncbi:5085">AF</span>
###xml 28 34 <span type="species:ncbi:10090">murine</span>
###xml 91 93 <span type="species:ncbi:5085">AF</span>
AF burden was quantified in murine lung at 24 and 48 hours following inhalation of 3.0x108 AF 293 conidia according to the methods of Bowman, et al[45]. Briefly, organ samples were mechanically disrupted using a roller-bottle method [46] and then vigorous agitation in a FastPrep 120 (Qbiogene; Carlsbad, CA) homogenizer. DNA was extracted from the homogenate using the DNeasy 96 Tissue Kit (Qiagen; Valencia, CA) according to the manufacturer's instructions. Oligonucleotide amplification primers and a dual-labeled fluorogenic oligonucleotide hybridization probe complementary to sequence from the 18S rRNA gene utilized by Bowman, et al [45]; were designed using Primer Express version 1.5 (Applied Biosystems; Foster City, CA). The sequences of these oligonucleotides are-
###end p 57
###begin p 58
###xml 28 54 28 54 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGCCCTTAAATAGCCCGGT-3&#8242;</named-content>
sense amplification primer: 5'- GGCCCTTAAATAGCCCGGT-3'
###end p 58
###begin p 59
###xml 32 57 32 57 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TGAGCCGATAGTCCCCCTAA-3</named-content>
antisense amplification primer: 5'-TGAGCCGATAGTCCCCCTAA-3
###end p 59
###begin p 60
###xml 7 43 7 43 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-6FAM-AGCCAGCGGCCCGCAAATG-TAMRA-3&#8242;</named-content>
probe: 5'-6FAM-AGCCAGCGGCCCGCAAATG-TAMRA-3'.
###end p 60
###begin p 61
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 155 174 155 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eimeria tenella PKG</italic>
###xml 252 262 252 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. tenella</italic>
###xml 128 134 <span type="species:ncbi:10090">murine</span>
###xml 155 170 <span type="species:ncbi:5802">Eimeria tenella</span>
###xml 252 262 <span type="species:ncbi:5802">E. tenella</span>
Modifications to the published protocol include the normalization of DNA content by a spike addition of 2x106 copies of the non-murine, non-fungal plasmid Eimeria tenella PKG cDNA (Accession Number AF411961), with normalization of results to amount of E. tenella DNA extracted (Bowman, et al; unpublished data). After homogenization and DNA isolation, samples are analyzed by TaqMan with the following primers and probe specific for the parasite gene sequence:
###end p 61
###begin p 62
###xml 28 52 28 52 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGGGCTTTGCTGCACGAC-3&#8242;</named-content>
sense amplification primer: 5'-AGGGCTTTGCTGCACGAC-3'
###end p 62
###begin p 63
###xml 32 57 32 57 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCCACCTCGGGACTGTTTG-3&#8242;</named-content>
antisense amplification primer: 5'-TCCACCTCGGGACTGTTTG-3'
###end p 63
###begin p 64
###xml 21 61 21 61 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- FAM-TGCTACTGTTGCAGACCGCCGCT-TAMRA-3&#8242;</named-content>
hybridization probe: 5'- FAM-TGCTACTGTTGCAGACCGCCGCT-TAMRA-3'
###end p 64
###begin p 65
TaqMan quantification of the PKG target sequence allows for an estimate of the recovery of DNA in the experiment from the crude homogenate through the TaqMan reaction. This assessment of DNA recovery was made for each experimental sample. The percent recovery of the PKG target sequence was used to estimate the recovery of tissue DNA from the sample. Accordingly, each TaqMan data point for the AF18S rRNA gene target was normalized based on the recovery of DNA predicted by the PKG standard. Data were analyzed using GraphPad Prism version 4.0 for Windows, (GraphPad Software, San Diego, CA, ).
###end p 65
###begin title 66
###xml 24 29 <span type="species:ncbi:10090">Mouse</span>
###xml 34 39 <span type="species:ncbi:9606">Human</span>
Fluorescent Labeling of Mouse and Human Plasminogen
###end title 66
###begin p 67
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 361 366 <span type="species:ncbi:9606">human</span>
Purified mouse plasminogen prepared from outbred mice (Haematologic Technologies) was dialyzed against PBS and labeled with AlexaFluor 488 per the manufacturers instructions (Invitrogen). The moles dye per mole protein binding ratio of labeled plasminogen was 5. Free dye was removed by dialyzing labeled protein for 24 hours against PBS at 4degreesC. Purified human glu-plasminogen (Haematologic Technologies) was labeled in the same manner, with a moles dye per mole protein binding ratio of 6.
###end p 67
###begin title 68
###xml 23 35 23 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 23 35 <span type="species:ncbi:5085">A. fumigatus</span>
Plasminogen Binding to A. fumigatus Conidia
###end title 68
###begin p 69
###xml 8 20 8 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 75 87 75 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 269 281 263 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 295 296 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 887 899 867 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 913 914 893 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 8 20 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 75 87 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 220 226 <span type="species:ncbi:10090">murine</span>
###xml 230 235 <span type="species:ncbi:9606">human</span>
###xml 269 281 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 398 403 <span type="species:ncbi:10090">mouse</span>
###xml 407 412 <span type="species:ncbi:9606">human</span>
###xml 593 599 <span type="species:ncbi:9913">bovine</span>
###xml 703 708 <span type="species:ncbi:9606">Human</span>
###xml 887 899 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 951 956 <span type="species:ncbi:10090">mouse</span>
###xml 960 965 <span type="species:ncbi:9606">human</span>
###xml 1034 1039 <span type="species:ncbi:10090">mouse</span>
###xml 1043 1048 <span type="species:ncbi:9606">human</span>
###xml 1184 1189 <span type="species:ncbi:9606">human</span>
###xml 1376 1381 <span type="species:ncbi:9606">Human</span>
Swollen A. fumigatus conidia were prepared by incubating freshly harvested A. fumigatus 293 conidia in RPMI for 6 hours at 37degreesC. Swollen conidia were washed with PBS prior to incubation with AlexaFluor 488 labeled murine or human plasminogen. Resting and swollen A. fumigatus conidia (1x107 conidia/ml) were treated with several concentrations (0.2 to 10 microg/ml) of AlexaFluor 488 labeled mouse or human plasminogen in PBS and incubated at 37degreesC for 30 minutes with shaking. As controls, swollen conidia were incubated with increasing concentrations (0.2 to 4 microg/mL) of FITC-bovine serum albumin (BSA) (Invitrogen). Plasminogen binding was quantified by flow cytometric analysis (Duke Human Vaccine Institute Flow Cytometry Core Facility and Flow Cytometric Core Facility, National Institute of Environmental Health Sciences). For competitive inhibition binding assays A. fumigatus conidia (1x107) were first treated with unlabelled mouse or human plasminogen (Haematologic Technologies) then AlexaFluor 488 labeled mouse or human plasminogen. Controls included swollen conidia pre-incubated in PBS-0.1% BSA overnight prior to incubation with AlexaFluor 488 labeled human plasminogen as described above. Conidia were incubated at 37degreesC for 30 minutes with shaking for each treatment. Plasminogen binding was quantified by flow cytometric analysis (Duke Human Vaccine Institute Flow Cytometry Core Facility and Flow Cytometric Core Facility, National Institute of Environmental Health Sciences). For microscopy, conidia were treated with Calcofluor white (Sigma Biochemicals) to visualize the cell wall. Binding was visualized using a Zeiss Axioskop 2 Plus (Carl Zeiss MicroImaging) fluorescent microscope with an AxioCam MRM digital camera.
###end p 69
###begin title 70
###xml 23 35 23 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 23 35 <span type="species:ncbi:5085">A. fumigatus</span>
Plasminogen Binding to A. fumigatus Hyphae
###end title 70
###begin p 71
###xml 104 105 104 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 155 156 149 150 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 543 555 527 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 88 90 <span type="species:ncbi:5085">AF</span>
###xml 365 370 <span type="species:ncbi:10090">mouse</span>
###xml 374 379 <span type="species:ncbi:9606">human</span>
###xml 543 555 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 598 603 <span type="species:ncbi:10090">mouse</span>
###xml 607 612 <span type="species:ncbi:9606">human</span>
###xml 711 716 <span type="species:ncbi:10090">mouse</span>
###xml 720 725 <span type="species:ncbi:9606">human</span>
10 ml of RPMI-1640 medium in a T-25 vented cap tissue culture flask was inoculated with AF conidia (1x107) and incubated overnight at 37degreesC with 5% CO2. Hyphae were collected by gentle vortexing of the tissue culture flask and 10 microl aliquots of hyphae were spotted onto glass slides and allowed to dry. Hyphae were then treated with AlexaFluor 488 labeled mouse or human plasminogen for 30 minutes at 37degreesC at varying concentrations and with Calcofluor white to visualize the cell wall. For competitive inhibition binding assays A. fumigatus hyphae were first treated with unlabelled mouse or human plasminogen (Haematologic Technologies) for 30 minutes at 37degreesC then Alexa Fluor 488 labeled mouse or human plasminogen (0.2 microg/ml) for 30 minutes at 37degreesC. Binding was visualized using a Zeiss Axioskop 2 Plus fluorescent microscope with an AxioCam MRM digital camera.
###end p 71
###begin title 72
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human Genomic Sequencing
###end title 72
###begin p 73
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Wall1">[47]</xref>
###xml 562 566 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Ascioglu1">[48]</xref>
###xml 681 684 681 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 754 757 754 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 1348 1351 1348 1351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 1402 1405 1402 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 30 38 <span type="species:ncbi:9606">patients</span>
###xml 462 470 <span type="species:ncbi:9606">patients</span>
###xml 576 584 <span type="species:ncbi:9606">patients</span>
###xml 748 753 <span type="species:ncbi:9606">human</span>
###xml 1182 1187 <span type="species:ncbi:9606">Human</span>
Genomic DNA was prepared from patients who received allogeneic hematopoietic stem cell transplant (HSCT) after myeloablative therapy at the Fred Hutchinson Cancer Research Center (Seattle, WA), and their donors. An immortalized lymphocyte cell line was created from each subject using peripheral blood mononuclear cells obtained prior to transplantation[47]. Genomic DNA was isolated using a Qia-Amp DNA blood Kit (Qiagen). The cohort represented a sample of 83 patients who developed proven or probable invasive aspergillosis, according to standardized criteria[48], and 147 patients who did not. Cases of "possible" aspergillosis were not included in the study. The plasminogen (PLG) gene extending from 2 kb 5' upstream to 1 kb 3' downstream of human PLG transcript was sequenced in 20 IA affected donor/recipient pairs using Applied Biosystems (AB) Version 3.1 Dye Terminators and an ABI 3730 Genetic Analyzer (Applied Biosystems). Polymorphisms were identified, and corresponding genotypes determined, by analysis of the resulting DNA sequence data using PHRED and PHRAP. Four coding change SNPs were identified and exons containing these SNPs (exons 2, 3, 11, and 12, Ensembl Human V.36) were further sequenced for all members of the cohort to determine their genotypes using PolyPhred. To identify potentially important sequence changes in hPLG, all exons and the 500 bp promoter region of the hPLG gene were sequenced in 20 HSCT donor-recipient pairs; nineteen SNPs were identified. Of the 19 SNPs, 11 SNPs were located in exons and 4 of them induced a change in an amino acid.
###end p 73
###begin p 74
###xml 219 226 219 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pgen-1000101-t001">Table 1</xref>
Exons containing these nonsynonymous coding change SNPs (exons 2, 3, 11, and 12) were sequenced in the remaining sample of 210 Caucasian donor/recipient pairs (63 with proven/probable IA, 147 without IA) (Demographics; Table 1). SNP Asp472Asn (rs4252125) at position 827 in exon 11 was the only one of the nonsynonymous coding change SNPs considered to be of further interest as it had a minor allele frequency of approximately 25%, while the other 3 SNPs had minor allele frequencies of <1%.
###end p 74
###begin p 75
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Lee1">[49]</xref>
###xml 896 900 896 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Prentice1">[50]</xref>
###xml 1478 1481 1478 1481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLG</italic>
###xml 1691 1694 1691 1694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Marr1">[2]</xref>
###xml 2815 2819 2815 2819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Greenland1">[51]</xref>
###xml 498 506 <span type="species:ncbi:9606">patients</span>
Statistical Methods: A Cox proportional hazards approach was used to model the hazard of IA in relation to the recipient genotype, over follow-up time after receipt of stem cells. Death and relapse were treated as censoring mechanisms [49]. Although the required proportional hazards assumption was not significantly violated, in the final modeling the follow-up for analysis was begun on day 40 following transplantation, though this left-truncation did not materially affect the results. Because patients developing IA were sampled with probability 0.25, while those who had remained free of IA were sampled with probability 0.09, the differential sampling had to be accounted for statistically. This was accomplished by designating a random 9/25 of the IA cases (31 of 83), together with all noncases, as members of a synthetic random subcohort, and applying software for case-cohort analysis [50]. In this way, the variances for parameter estimation were increased appropriately to account for the dependency induced by using the same controls in successive risk sets in modeling the risk of IA. This weighting was also accounted for in calculating Kaplan-Meier cumulative incidence curves. For multi-category variables, the improvement in fit provided by their inclusion in a model was tested by means of chi-squared statistics based on scores. To assess the proportionality assumption required by the Cox proportional hazards model, the relative risks associated with the PLG genotype were permitted to vary across two defined periods of time: days 40-100 and days more than 100 following receipt of stem cells, as these time intervals represent known differential risk periods for IA [2]. Additionally, we included models that allowed genotype (and certain other factors, such as HLA matching status) to have different effects during different epochs of follow-up. Division of time into epochs was based on knowledge of how clinical approaches to management are altered in the months following HSCT. Analyses were performed both for the entire available follow-up time, and with follow-up truncated at one year. Results are shown for the analysis beginning at 40 days and truncated at one year, but the inference is not materially different with inclusion of longer follow-up. Covariates considered for adjustment as possible confounders or effect modifiers included age, cell type, malignancy category, antifungal prophylaxis, gender, genotype of the donor, and HLA status of graft [matched related (6/6 match from relative); matched unrelated (6/6 match from non-relative) or mismatched]. Adjustment for development of graft-versus-host disease was considered, but judged not to be defensible as a legitimate potential confounder of recipient genotype, based on any plausible causal directed acyclic graph [51]. Possible effects of genotype on survival following IA were explored through a Cox proportional hazards analysis, with follow-up beginning the day after diagnosis of IA. The contribution of each variable to the final model was tested by means of score tests and all p values given are two-sided.
###end p 75
###begin p 76
###xml 45 53 <span type="species:ncbi:9606">patients</span>
Hardy-Weinberg equilibrium for the recipient patients was tested based on the members of the sub-cohort, while that for the donors were tested based on all the donors. Work was approved by the Institutional Review Boards of the Fred Hutchinson Cancer Research Center, Duke University Medical Center and the National Institute of Environmental Health Sciences.
###end p 76
###begin title 77
###xml 12 18 <span type="species:ncbi:10090">Murine</span>
###xml 23 28 <span type="species:ncbi:9606">Human</span>
Modeling of Murine and Human Plasminogen Amino Acid Changes
###end title 77
###begin p 78
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Cornell1">[52]</xref>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-CaseTAD1">[53]</xref>
###xml 827 831 827 831 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pgen.1000101-Nicholls1">[54]</xref>
###xml 12 18 <span type="species:ncbi:10090">murine</span>
###xml 107 112 <span type="species:ncbi:9606">human</span>
###xml 593 598 <span type="species:ncbi:9606">human</span>
###xml 860 865 <span type="species:ncbi:9606">human</span>
###xml 1120 1125 <span type="species:ncbi:9606">human</span>
A model for murine kringle-1 (K1) was created using the X-ray crystal structure of the kringle-1 domain of human plasminogen (pdb entry: 1CEA). All appropriate mutations required for this homology modeling were carried out using Sybyl 7.1 (Tripos, Inc.). The structure was then energy minimized in vacuum using the Amber force field (FF03) [52]. Gly6 was then mutated to Ser and the structure was re-minimized using the above force field. Minimization was performed using the Sander module of the molecular dynamics package Amber 9.0 [53]. All hydrogens were added to the crystal structure of human plasminogen K1 (pdb entry: 1CEA) and the sidechains were energy minimized (in vacuum) using the Amber force field (FF03). The electrostatic potential surfaces of the minimized structures were constructed using the program Grasp [54]. For modeling the change in human plasminogen, the combined K4K5 domains along with the connecting region was modeled using the crystal structures of the individual kringle domains (K4 from PDB entry 2PK4 and K5 from PDB entry 5HPG) and the X-ray crystal structure of K1-K2-K3 domains of human angiostatin. The K1-K2 relative domain arrangement in angiostatin was used as the initial template for K4 superimposed on K1 and K5 superimposed on K2 and the loop building using homology modeling package Sybyl 7.1 (Tripos, Inc.) yielded the initial structure of K4K5 domains. A subsequent minimization followed by a nanosecond molecular dynamics simulation using Generalized Born solvation model (Amber 9.0) was used to obtain the final representative structure for K4K5 of plasminogen. Asp472 in the native K4K5 structure was mutated to Asn and the resultant structure was subjected to a minimization followed by a nanosecond generalized Born salvation dynamics trajectory calculation to obtained the representative structure of the K4K5 (Asp472Asn) mutant structure.
###end p 78
###begin title 79
Supporting Information
###end title 79
###begin p 80
###xml 124 136 124 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A. fumigatus</italic>
###xml 124 136 <span type="species:ncbi:5085">A. fumigatus</span>
(A) Computational prediction of chromosomal regions regulating outcome following immune suppression and exposure to inhaled A. fumigatus. Segments are arranged from centromeric to telomeric for all 19 autosomes. Each bar represents a 30-cM interval, and neighboring bars are offset by 10 cM. The dotted line represents a useful cutoff for analyzing this data; the most highly correlated 10% of the loci are above this line. (B) After exclusion of the DBA/2J strain, the interval containing Plg remains among the top predicted loci.
###end p 80
###begin p 81
(0.03 MB PDF)
###end p 81
###begin p 82
Click here for additional data file.
###end p 82
###begin p 83
###xml 277 279 <span type="species:ncbi:5085">AF</span>
###xml 361 363 <span type="species:ncbi:5085">AF</span>
Computational genetic analysis identifies plasminogen (Plg) as a candidate susceptibility gene for invasive aspergillosis. Haplotype-based computational genetic analysis was used to analyze the area under the survival curve to identify genetic factors affecting survival after AF exposure among the inbred strains. The area under the survival curve (AUC) after AF exposure was analyzed for 9 inbred strains. There were several haplotype blocks that had a strong correlation with survival curve AUC with P value less than 0.01, including the block containing Plg. However, Plg remained a top biologically plausible candidate. Red blocks indicate haplotypes for the "resistant" strains (Balb/CJ, Balb/CbyJ, C57Bl/6J, AKR/J and 129/SvJ) and the "intermediate" strain NZW/LacJ, and the blue blocks indiciate "susceptible" strains (C3H/HeJ and A/J) and the "intermediate" strain MRL/MpJ.
###end p 83
###begin p 84
(0.19 MB PDF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 33 39 <span type="species:ncbi:10090">murine</span>
###xml 44 50 <span type="species:ncbi:10090">murine</span>
###xml 497 502 <span type="species:ncbi:9606">human</span>
###xml 516 522 <span type="species:ncbi:10090">murine</span>
###xml 536 542 <span type="species:ncbi:10090">murine</span>
Ribbon diagrams of (A) human (C) murine (E) murine (Gly6Ser) plasminogen kringle-1 structures. Amino acid numbering for this model is used for kringle 1 only, thus Gly6 in this model corresponds to Gly110 in the full plasminogen structure. Gly6 (and Ser6 in the mutated structure) are shown as space filling models on the ribbon diagram. Also shown are Asp55 and Asp57 (above Gly6), the key lysine binding residues in kringle-1. Corresponding electrostatic potential surfaces are shown in (B) for human K-1, (D) for murine, and (F) for murine (Gly6Ser) structures. Notably, the negativity of the electrostatic potential surface is enhanced in the variant plasminogen, thus possibly increasing the affinity of lysine binding. The area of the lysine binding site is circled.
###end p 86
###begin p 87
(0.48 MB PDF)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin p 89
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 427 429 <span type="species:ncbi:5085">AF</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 501 503 <span type="species:ncbi:5085">AF</span>
###xml 566 568 <span type="species:ncbi:5085">AF</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 638 642 <span type="species:ncbi:10090">mice</span>
###xml 863 867 <span type="species:ncbi:10090">mice</span>
White blood cell (WBC) and absolute neutrophil counts (ANC) were measured in each mouse strain at the indicated times after administration of cyclophosphamide and cortisone acetate (n = 5 mice/strain). Neutropenia/leukopenia are present at time of inhalation (day 0) through day 7, and recover by day 10 following inhalation. The pulmonary Aspergillus burden was measured by RT-PCR 24 and 48 hours after inhalation of 3.0x10e8 AF conidia. Of note, all mice had equivalent fungal burden 24 hours after AF exposure (P = NS, Wilcoxon rank sum). However, 48 hours after AF exposure, mice from sensitive inbred strains (A/J and C3H/HEJ, n = 4 mice/strain) had increased fungal burden from initial values (median conidial equivalents 4.7 log cells/gram lung tissue; range 3.8-5.0) versus resistant inbred strains (AKR/J, 129/SvJ, C57/Bl6, Balb/C and Balb/CByJ; n = 4-5 mice/strain) did not increase their fungal burden (median conidial equivalents 3.7 log cells/gram lung tissue; range 2.7-5.3; p = 0.02, Mann-Whitney test).
###end p 89
###begin p 90
(0.10 MB DOC)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
The authors gratefully acknowledge the assistance of W. Michael Foster, PhD (Duke University Medical Center; NIEHS #ES-011961) and William J. Steinbach, MD (Duke University Medical Center) in the development and implementation of the inhalational chamber and the Duke University Medical Center Flow Cytometry Core Facility and the Flow Cytometry Center at the National Institute for Environmental Health Sciences for assistance with flow cytometry.
###end p 92
###begin title 93
References
###end title 93
###begin article-title 94
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
###end article-title 94
###begin article-title 95
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.
###end article-title 95
###begin article-title 96
###xml 52 56 <span type="species:ncbi:10090">mice</span>
Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.
###end article-title 96
###begin article-title 97
###xml 55 59 <span type="species:ncbi:10090">mice</span>
In silico mapping of complex disease-related traits in mice.
###end article-title 97
###begin article-title 98
In silico pharmacogenetics of warfarin metabolism.
###end article-title 98
###begin article-title 99
In silico genetics: identification of a functional element regulating H2-Ealpha gene expression.
###end article-title 99
###begin article-title 100
Modulation of pro- and antiapoptotic molecules in double-positive (CD4+CD8+) thymocytes following dexamethasone treatment.
###end article-title 100
###begin article-title 101
###xml 46 68 <span type="species:ncbi:1314">Streptococcus pyogenes</span>
PAM, a novel plasminogen-binding protein from Streptococcus pyogenes.
###end article-title 101
###begin article-title 102
###xml 25 58 <span type="species:ncbi:2105">Mycoplasma species bovine group 7</span>
Cell surface antigens of Mycoplasma species bovine group 7 bind to and activate plasminogen.
###end article-title 102
###begin article-title 103
###xml 34 40 <span type="species:ncbi:9606">humans</span>
The interaction of pathogens with humans.
###end article-title 103
###begin article-title 104
Use of the plasminogen activation system by microorganisms.
###end article-title 104
###begin article-title 105
###xml 38 43 <span type="species:ncbi:9606">human</span>
On the mechanism of the activation of human plasminogen by recombinant staphylokinase.
###end article-title 105
###begin article-title 106
###xml 0 16 <span type="species:ncbi:5476">Candida albicans</span>
###xml 23 28 <span type="species:ncbi:9606">human</span>
Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins.
###end article-title 106
###begin article-title 107
###xml 70 90 <span type="species:ncbi:4754">Pneumocystis carinii</span>
Plasminogen-binding activity of enolase in the opportunistic pathogen Pneumocystis carinii.
###end article-title 107
###begin article-title 108
Two-way interactions between inflammation and coagulation.
###end article-title 108
###begin article-title 109
Divergence in the plasminogen-binding group a streptococcal M protein family: functional conservation of binding site and potential role for immune selection of variants.
###end article-title 109
###begin article-title 110
###xml 40 55 <span type="species:ncbi:632">Yersinia pestis</span>
Plasminogen activator/coagulase gene of Yersinia pestis is responsible for degradation of plasmid-encoded outer membrane proteins.
###end article-title 110
###begin article-title 111
Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.
###end article-title 111
###begin article-title 112
Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
###end article-title 112
###begin article-title 113
Functional hierarchy of plasminogen kringles 1 and 4 in fibrinolysis and plasmin-induced cell detachment and apoptosis.
###end article-title 113
###begin article-title 114
Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface.
###end article-title 114
###begin article-title 115
Bacterial plasminogen activators and receptors.
###end article-title 115
###begin article-title 116
###xml 11 27 <span type="species:ncbi:5476">Candida albicans</span>
###xml 85 90 <span type="species:ncbi:9606">human</span>
Binding of Candida albicans enolase to plasmin(ogen) results in enhanced invasion of human brain microvascular endothelial cells.
###end article-title 116
###begin article-title 117
###xml 0 20 <span type="species:ncbi:1309">Streptococcus mutans</span>
###xml 72 77 <span type="species:ncbi:9606">human</span>
Streptococcus mutans surface alpha-enolase binds salivary mucin MG2 and human plasminogen.
###end article-title 117
###begin article-title 118
###xml 21 42 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Interactions between Aspergillus fumigatus and host matrix proteins.
###end article-title 118
###begin article-title 119
###xml 62 83 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia.
###end article-title 119
###begin article-title 120
Plasminogen Inhibits TNF{alpha}-induced Apoptosis in Monocytes.
###end article-title 120
###begin article-title 121
###xml 94 98 <span type="species:ncbi:10090">mice</span>
Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice.
###end article-title 121
###begin article-title 122
Ciglitazone inhibits plasmin-induced proinflammatory monocyte activation via modulation of p38 MAP kinase activity.
###end article-title 122
###begin article-title 123
###xml 64 69 <span type="species:ncbi:9606">human</span>
Plasmin is a specific stimulus of the 5-lipoxygenase pathway of human peripheral monocytes.
###end article-title 123
###begin article-title 124
TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation.
###end article-title 124
###begin article-title 125
Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation.
###end article-title 125
###begin article-title 126
###xml 12 33 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Immunity to Aspergillus fumigatus: the basis for immunotherapy and vaccination.
###end article-title 126
###begin article-title 127
TLRs govern neutrophil activity in aspergillosis.
###end article-title 127
###begin article-title 128
###xml 0 21 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Aspergillus fumigatus induces innate immune responses in alveolar macrophages through the MAPK pathway independently of TLR2 and TLR4.
###end article-title 128
###begin article-title 129
###xml 88 94 <span type="species:ncbi:10090">murine</span>
Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages.
###end article-title 129
###begin article-title 130
###xml 0 21 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
Aspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transduction.
###end article-title 130
###begin article-title 131
Cytokine responses to fungal pathogens in Kupffer Cells are Toll-like receptor 4 independent and mediated by tyrosine kinases.
###end article-title 131
###begin article-title 132
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis.
###end article-title 132
###begin article-title 133
Animal exposure chambers in air pollution studies.
###end article-title 133
###begin article-title 134
Value of an inhalational model of invasive aspergillosis.
###end article-title 134
###begin article-title 135
###xml 51 55 <span type="species:ncbi:10090">mice</span>
In silico and in vitro pharmacogenetic analysis in mice.
###end article-title 135
###begin article-title 136
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 38 43 <span type="species:ncbi:9606">human</span>
Computational genetics: from mouse to human?
###end article-title 136
###begin article-title 137
###xml 50 54 <span type="species:ncbi:10090">Mice</span>
Haplotype-Based Computational Genetic Analysis in Mice.
###end article-title 137
###begin article-title 138
###xml 34 55 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 68 74 <span type="species:ncbi:10090">murine</span>
Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.
###end article-title 138
###begin article-title 139
###xml 92 108 <span type="species:ncbi:5476">Candida albicans</span>
Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans.
###end article-title 139
###begin article-title 140
###xml 32 50 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 70 75 <span type="species:ncbi:9606">human</span>
An efficient method for routine Epstein-Barr virus immortalization of human B lymphocytes.
###end article-title 140
###begin article-title 141
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
###end article-title 141
###begin article-title 142
EPICURE User's Guide: Hirosoft International
###end article-title 142
###begin article-title 143
Causal diagrams for epidemiologic research.
###end article-title 143
###begin article-title 144
A second generation force field for the simulation of proteins, nucleic acids, and organic molecules.
###end article-title 144
###begin article-title 145
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.
###end article-title 145
###begin p 146
Aimee K. Zaas, MD serves on the speaker's bureau for Pfizer, Inc. John R. Perfect is a consultant for the Robert Michael Educational Institute. Guochun Liao, Jonathan Usuka and Gary Peltz are employees of Roche Biosciences. All other authors declare that no conflict of interest exists.
###end p 146
###begin p 147
This work was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences. This work was supported in part by Grant # K08AI065837 (AKZ) from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily reflect the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. GL, JU and GP are employees of Roche Biosciences.
###end p 147

